Caricamento...

Enhanced Accumulation of Cisplatin in Ovarian Cancer Cells from Combination with Wedelolactone and Resulting Inhibition of Multiple Epigenetic Drivers

PURPOSE: Cisplatin resistance is a major concern in ovarian cancer treatment. The aim of this study was to investigate if wedelolactone could perform better in resistant ovarian cancer cells when used in combination with cisplatin. METHODS: Growth inhibitory potential of wedelolactone and cisplatin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drug Des Devel Ther
Autori principali: Sarwar, Sadia, Alamro, Abir A, Alghamdi, Amani A, Naeem, Komal, Ullah, Salamat, Arif, Muazzam, Yu, Jun Qing, Huq, Fazlul
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2021
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8164677/
https://ncbi.nlm.nih.gov/pubmed/34079223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S288707
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !